What is NDC 64980-602?

64980-602 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 20 mg/1 tablet, coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Olmesartan Medoxomil?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Olmesartan Medoxomil NDC 64980-602

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-602Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0602Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64980-602-03	6498006020364980060203	30 TABLET, COATED in 1 BOTTLE (64980-602-03)Marketed from Mar 30, 2024
64980-602-09	6498006020964980060209	90 TABLET, COATED in 1 BOTTLE (64980-602-09)Marketed from Mar 30, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Olmesartan Medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 20 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208659
Marketing start: Mar 30, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 64980-602_4e8b4338-7c4c-4af4-8658-660111a8b966SPL ID 4e8b4338-7c4c-4af4-8658-660111a8b966SPL set ID b02ff20e-3f0e-43f4-a7b5-6ce56295d023RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0364980601092, 0364980603034, 0364980601030, 0364980602037, 0364980602099, 0364980603096
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980060203 followed by a unit qualifier and the quantity

Package 64980-0602-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 16, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil tablet are indicated for the treatment of hypertension, in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-602

What is NDC 64980-602?: 64980-602 is the product NDC for Olmesartan Medoxomil, Olmesartan medoxomil 20 mg/1 tablet, coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Olmesartan Medoxomil.
What is the active ingredient?: Olmesartan medoxomil.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Olmesartan Medoxomil?: 122 other product NDCs are listed under this name. See all Olmesartan Medoxomil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Olmesartan Medoxomil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	NorthStar RxLLC	72603-950	72603-0950-0172603-0950-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	NorthStar RxLLC	72603-951	72603-0951-0172603-0951-02
Olmesartan medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	NorthStar RxLLC	72603-952	72603-0952-0172603-0952-02
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0848	72303-0848-0172303-0848-02
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0849	72303-0849-0172303-0849-02
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0850	72303-0850-0172303-0850-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4598	70518-4598-00
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011	60290-0011-0160290-0011-0260290-0011-03
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-009	60290-0009-0160290-0009-0260290-0009-03
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010	60290-0010-0160290-0010-0260290-0010-03

All 123 Olmesartan Medoxomil NDCs

Other NDCs under ANDA 208659

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208659
Product	Strength	Form · route	Labeler	Product NDC
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, CoatedOral	Inventia Healthcare Limited	49252-065
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, CoatedOral	Inventia Healthcare Limited	49252-066
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, CoatedOral	Inventia Healthcare Limited	49252-067
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, CoatedOral	Rising Pharma Holdings, Inc.	64980-603
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, CoatedOral	Rising Pharma Holdings, Inc.	64980-665
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, CoatedOral	Bryant Ranch Prepack	71335-2996